TUDCA-ALS study continues despite COVID-19 outbreak

We would like to reassure you that despite the recent outbreak of COVID-19 epidemics across Europe, that all TUDCA-ALS trial activities are currently ongoing.

There continues to be regular shipments of the tablets that the participants are taking as part of the study (known as the Investigational Medicinal Product or IMP) as well as the shipments of the equipment and materials required to collect biological samples.

Despite the restrictions on travel within Italy, patients are permitted to travel in order to attend medical assessments.
We will of course provide further updates if the situation changes in the future.